Precision Health Informatics is a data science and technology company dedicated to using data-driven insights and evidence-based learning to transform cancer patient outcomes and experiences.
Working closely with life science and pharmaceutical companies, payors and data aggregators, Precision Health Informatics taps extensive patient data and real-world evidence to provide clinicians and researchers with treatments that are highly customized and matched to individual patient differences.
Precision Health Informatics is a wholly-owned subsidiary of Texas Oncology, an independent private practice with more than 530 physicians that see more than 71,000 new cancer patients annually at 280 locations across Texas. Texas Oncology’s robust community-based clinical trials and research program has contributed to the development of more than 100 FDA-approved cancer therapies.
Precision Health Informatics is at the forefront of applying precision medicine to treating cancer more precisely and effectively with fewer negative side effects. Its EMR integrated bioinformatics platform is a clinical data repository, with healthcare information as well as patient journey data from more than 1.6 million patients.
Precision Health Informatics’s platform is seamlessly integrated with clinical and laboratory services, including datasets of more than 175,000 molecular profiles across tumor types. The unique insights derived from Precision Health Informatics’ extensive and diverse data advances clinical research capabilities, personalizes patient care, and simultaneously captures drug utilization and payer reimbursement information.